Process for preparing pharmaceutically active compounds

Organic compounds -- part of the class 532-570 series – Organic compounds – Pteroyl per se or having -c- – wherein x is chalcogen – bonded...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S118000, C544S357000, C546S275400

Reexamination Certificate

active

10753199

ABSTRACT:
A process for the preparation of Compounds of the formula (1):wherein R1, R2, R4and R13are as defined or a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or pro-drug thereof: are potent and selective inhibitors of type 5 cyclic guanosine 3′,5′-monophosphate phosphodiestbrase (cGMP PDE5) and have utility in the treatment of, inter alia, male erectile dysfunction (MED) and female sexual dysfunction (FSD).

REFERENCES:
patent: 2089971 (1937-08-01), Lesser
patent: 4663326 (1987-05-01), Hamilton
patent: 4666908 (1987-05-01), Hamilton
patent: 4871843 (1989-10-01), Roger et al.
patent: 5250534 (1993-10-01), Bell et al.
patent: 5272147 (1993-12-01), Bell et al.
patent: 5294612 (1994-03-01), Bacon et al.
patent: 5346901 (1994-09-01), Bell et al.
patent: 5426107 (1995-06-01), Bell et al.
patent: 5719283 (1998-02-01), Bell et al.
patent: 5734053 (1998-03-01), Terrett
patent: 5736548 (1998-04-01), Bacon et al.
patent: 5955611 (1999-09-01), Dunn et al.
patent: 6420557 (2002-07-01), Harris et al.
patent: 6699991 (2004-03-01), James et al.
patent: 2002/0040140 (2002-04-01), Harris et al.
patent: 19540642 (1997-05-01), None
patent: 0201188 (1986-12-01), None
patent: 0352960 (1990-01-01), None
patent: 0463756 (1992-01-01), None
patent: 0526004 (1993-02-01), None
patent: 0349239 (1994-03-01), None
patent: 0636626 (1995-02-01), None
patent: 0425921 (1995-08-01), None
patent: 0812845 (1997-12-01), None
patent: 0992240 (2000-04-01), None
patent: 0995750 (2000-04-01), None
patent: 1020190 (2000-07-01), None
patent: 1074258 (2001-02-01), None
patent: 1090644 (2001-04-01), None
patent: 1092720 (2001-04-01), None
patent: 2000119198 (2000-04-01), None
patent: WO 9306104 (1993-04-01), None
patent: WO 9307149 (1993-04-01), None
patent: WO 9312095 (1993-06-01), None
patent: WO 9315062 (1993-08-01), None
patent: WO 9400453 (1994-01-01), None
patent: WO 9405661 (1994-03-01), None
patent: WO 9428902 (1994-12-01), None
patent: WO 9509636 (1995-04-01), None
patent: WO 9616644 (1996-06-01), None
patent: WO 9616657 (1996-06-01), None
patent: WO 9628429 (1996-09-01), None
patent: WO 9628448 (1996-09-01), None
patent: WO 9843614 (1998-10-01), None
patent: WO 9049166 (1998-11-01), None
patent: WO 9852569 (1998-11-01), None
patent: WO 9930697 (1999-06-01), None
patent: WO 9954333 (1999-10-01), None
patent: WO 9959584 (1999-11-01), None
patent: WO 9964004 (1999-12-01), None
patent: WO 0020033 (2000-04-01), None
patent: WO 0023056 (2000-04-01), None
patent: WO 0024745 (2000-05-01), None
patent: WO 0037061 (2000-06-01), None
patent: WO 0044399 (2000-08-01), None
patent: WO 0053148 (2000-09-01), None
patent: WO 0108659 (2001-02-01), None
patent: WO 0110406 (2001-02-01), None
patent: WO 0127113 (2001-04-01), None
Czarmiecki et al, Annual Reports in Medicinal Chemistry, 31, 61-70, Dec. (1996).
Henze et al., J. Am. Chem. Soc., Feb. 1939, pp. 433-435.
Terfort et al., J. Chem. Soc. Perkin trans. 1, 1996, pp. 1467-1479.
Dumaltre, J. Med. Chem., 1996, 39, 1635-1644.
Terrett, et al., Bioorg. Med. Chem. Lett, vol. 6, No. 15, 1996, pp. 1819-1824.
Gazz. Chim. Ital., vol. 72, 1942, pp. 325-333.
Hamilton et al., J. Med. Chem. vol. 30, No. 1, 1987, pp. 91-96.
Billotte, SYNLETT, Apr. 1998, pp. 379-380.
Jung, et al., Org. Chem. vol. 56, No. 24, 1991.
Anderson et al., J. org. Chem., vol. 37, No. 24, 1972, pp. 3953-3955.
Byeongmoon, et al., Nature, vol. 388, No. 28, pp. 860-862, Aug. 1997.
Hostyn, et al., J. Fr. Opthalmol., vol. 19, No. 2, pp. 133-139, 1996.
Hye Jung Lee et al., The J. of Pharmacology, vol. 281, No. 3, pp. 1431-1439, 1997.
OluFunmi et al., Nature Medicine, vol. 2, No. 7, pp. 795-799, Jul. 1996.
Takada et al., PDA Jrnl of Pharm. Science and Tech., vol. 49 No. 4, pp. 180-184, Jul.-Aug. 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for preparing pharmaceutically active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing pharmaceutically active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing pharmaceutically active compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3853760

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.